Compare SCTX & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCTX | DNUT |
|---|---|---|
| Founded | 2017 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.5M | 577.8M |
| IPO Year | 2026 | 2021 |
| Metric | SCTX | DNUT |
|---|---|---|
| Price | $17.20 | $2.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | ★ $57.00 | $4.08 |
| AVG Volume (30 Days) | 271.3K | ★ 1.7M |
| Earning Date | 09-02-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,522,616,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.31 | $2.87 |
| 52 Week High | $39.60 | $5.11 |
| Indicator | SCTX | DNUT |
|---|---|---|
| Relative Strength Index (RSI) | 34.53 | 30.91 |
| Support Level | N/A | N/A |
| Resistance Level | $26.50 | $3.69 |
| Average True Range (ATR) | 3.71 | 0.08 |
| MACD | -1.36 | -0.02 |
| Stochastic Oscillator | 4.94 | 3.57 |
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.